IGF1 and atrial fibrillation: We selected the transgenic models based on characteristics, features and underlying mechanisms common to human AF and physiological conditions, i.e. a fall in IGF1R/PI3K signalling in human AF [15,16] and increased IGF1 with physiological hypertrophy in humans [57].